SlideShare une entreprise Scribd logo
1  sur  33
Indole-3-Carbinol

Properties, Targets, Required Animal Data

Dr. Bhaswat S. Chakraborty

1
•
•

Indole-3-carbinol (I3C) belongs to dietary polyphenols which include
flavonoids, stillbenes, lignas, and phenolic acids
I3C is produced by the breakdown of the glucosinolate viz. glucobrassicin
– found at relatively high levels in cruciferous vegetables, e.g., broccoli, cabbage,
cauliflower, brussels sprouts, collard greens and kale
– cruciferous vegetables differ from other classes of vegetables in that they are rich
sources of sulfur-containing compounds (glucosinolates)
– cruciferous vegetables are associated with lower risk of several types of cancer
(epidemiologic evidence)
2
• I3C:
–
–
–
–
–
–
–
–

Off-white powder; mixes with water
Average Molecular Weight 147.1739
Melting Point 90 °C
Water Solubility 3.75 g/L
pKa ? (can act as both an electron donor & acceptor)
pH (1% solution) ?
storage temp. 2-8°C
Oral formulations can be made
3
•
•
•

Hydrolysis of glucobrassicin by myrosinase at neutral pH results in an unstable
indole isothiocyanate that degrades to form I3C and a thiocyanate ion
At acidic pH (stomach), I3C condenses to dimers (3,3'-diindolylmethane, DIM) &
trimers (Cyclononal tri-indole, CT)
When cruciferous vegetables are cooked (inactivating myrosinase), glucobrassicin
hydrolysis by intestinal bacteria still results in some I3C formation, whereas DIM &
CT do not form in alkaline pH of intestine
4
QSAR & CoMFA
•
•
•

•

•

At least one 3D-QSAR Comparative Molecular Field Analysis (CoMFA)
study of 14 DIM derivatives is reported
The CoMFA model derived from DIM analogues proved a good predictive
ability
Some newly designed compounds exhibited 3-fold more potent radical
scavenging activity than reference substance Vitamin E in DPPH model
expressed by IC50 values
The primary antitumor screening essay showed that some DIM derivatives
designed exhibited the inhibitory activities to some tumor cell growth at
relatively high concentration, and DIM was the most effective among
them
Relaiable 3D-QSAR model can be developed for radical scavenging
activities and anticancer assays in vitro.

Benabadji SH et al., Acta Pharmacol Sin 2004; 25: 666-671

5
PK of I3C
•
•

Very little data
Gastric acid converts I3C to active metabolites DIM and indolylcarbazole,
which are further metabolized in the liver
– most metabolites are excreted through the feces
– Conversion from I3C into DIM not only requires a precise acidity, it requires
time. This conversion may proceed slowly, requiring more time than most
foods typically spend in the intestinal tract

•
•
•

Following an oral dose of I3C in humans, only DIM and no I3C was found
circulating in the bloodstream of human subjects
Over 90% of an oral dose of I3C is converted into non-DIM condensation
products of uncertain structure, uptake and activity
I3C induces CYP 1A2 and can reduce serum concentration of drugs
metabolized by this enzyme

Arneson, DW et al., Proceedings of the American Association for Cancer Research, 1999 Mar; (40): #2833
Cover CM, et al. Cancer Res 1999; 59:1244-51
Yoshida M et al., Carcinogenesis. 2004 Nov;25(11):2257-64

6
Anti-Inflammatory Properties and
Mechanisms

7
• Several dietary polyphenol compounds (e.g. resveratrol,
genistein, catechin, and indole-3-carbinol) have been studied
for inflammation and cancer.
• The potential molecular mechanisms of their antiinflammatory activities have also been suggested to include
inhibition of enzymes related to inflammation:
–
–
–
–
–

cyclooxygenase and lipoxygenase
PPAR
NOS
NF-κB
NAG-1

• Mainly
– AA-Dependent pathway
– AA-Independent pathway
Baek SJ et al. Carcinogenesis, 2004;25:2425-32.
Baek SJ et al. Carcinogenesis, 2002;23:425-34.
Lee SH, et al. Biochem Biophys Res Commun, 2005;328:63-9.
Wilson LC et al. Int J Cancer 2003;105:747-53.
8
AA- Dependent Mechanisms
•
•

Aspirin and other NSAIDs block COX-1 and COX-2
The role of COX inhibition by I3C is not very clear but all NF-κB-regulated gene
products including COX-2 are down-regulated by I3C
– however, some dietary polyphenols, such as galangin and luteolin, and curcumin inhibit AA
peroxidation

•

•

•
•
•

Flavonols, including kaempferol, quercetin, morin and myricetin, were found to be 5LOX inhibitors. Hamamelitannin and the galloylated proanthocyanidins were found
to be the most potent inhibitors of 5-LOX.
In contrast, there are few reports regarding 12-LOX inhibition. Using bovine PMNs
and 12-LOX from bovine platelets, kuwanson C and quercetin potently inhibit 12-LOX
activity
Again, LOX inhibition by I3C is not very clear but all NF-κB-regulated gene products
including LOX are down-regulated by I3C and DIM
Both COX and LOX are blocked by curcumin
Quercetin was found to be an effective inhibitor of PLA2 in human38 and rabbit39
leukocytes. Quercetagetin, kaempferol-3-O-galactoside, and scutellarein inhibited
human recombinant synovial PLA2.

Yoon J-H & Baek SJ, Yonsei Medical Journal 2005, 46, 585 - 596

9
10
AA- Independent Mechanisms
•
•

•
•
•

•

•
•

PPARs (nuclear hormone receptors) regulate many inflammatory cytokines at the transcriptional
level, either enhancing or inhibiting inflammation process
Genistein increased the expression of lipid catabolism genes (this effect is not estrogen receptordependent, but PPARα-dependent). EGCG also binds to PPARα. Amentoflavone up-regulates
PPARγ expression in A549 human lung epithelial cells.
Few studies regarded polyphenols as PPAR ligands, but it is probable that polyphenols may also
affect PPAR protein expression, which results in the activation of the PPAR pathway
Effect of I3C on PPARs not reported
Nitric oxide synthase (NOS) endothelial NOS (eNOS), neuronal NOS (nNOS) and inducible NOS
(iNOS): many polyphenols, including 6-gingerol,64 EGCG,65 resveratrol, indole-3-carbinol, and
oroxylin A, inhibit NOS expression in LPS-induced RAW264.7 cells (these effects are probably
mediated by NF-κB)
Nuclear transcription factor κB (NF-κB): Quercetin was reported to suppress TNF-α induced
expression of IL-8 and monocyte chemoattractant protein (MCP-1) due to its ability to inhibit the
activation of NF-κB. Quercetin also inhibited the NF-κB pathway without any modification of c-Jun
N- terminal kinase activity both in vivo & in vitro
Recently, it has been reported that I3C inhibits NF-κB and NF-κB-regulated gene expression.
NAG-1 (NSAID activated gene-1): I3C and other polyphenols induce NAG-1 expression, except (-)
-epicatechin (EC) and (-)-epigallocatechin (EGC), indicating the structure-specific expression of
NAG-1 induction
Yoon J-H & Baek SJ, Yonsei Medical Journal 2005, 46, 585 - 596

11
Anticancer Properties &
Mechanisms

12
Anticancer Properties
•

I3C & DIM are good candidates for cancer prevention. Several studies
demonstrate that they
–
–
–
–

•

can cause cell cycle arrest and apoptosis in cancer cell lines
have antiangiogenic activity
inhibit tobacco smoke-induced lung adenocarcinoma in mice
I3C enhances efficacy of gemcitabine and acts synergistically with bortezomib in vitro.

Clinical trial data show that I3C is effective in treatment of precancerous cervical
dysplasia and vulvar intraepithelial neoplasia
– In premenopausal women, a supplement containing I3C and 7-hydroxymatairesinol
significantly increased the urinary 2:16-hydroxyestrone ratio, a known biomarker for the
reduction of breast cancer risk

•
•

I3C also stimulates detoxification enzymes in the gut and liver
I3C is generally well tolerated when taken orally
– it may, however, promote tumor growth in animals that have been exposed to
carcinogens
– because it induces cytochrome P450 enzymes, I3C may interact with several
medications
13
Nuclear factors modulated by I3C
•

Four nuclear transcription factors interact with I3C and DIM
–
–
–
–

•

estrogen receptor (ER)
Sp1
nuclear factor кB (NFкB)
aryl hydrocarbonreceptor (AhR)

These may account for changes in downstream events in normal and neoplastic
cells.

Y.S. Kim, J.A. Milner. J Nutri Biochem 16 (2005) 65–73

14
DIM Resource Centre, University of California at Berkeley

15
DIM Resource Centre, University of California at Berkeley

16
17
DIM Resource Centre, University of California at Berkeley
Chemical structures of I3C and DIM and summary of their key modulatory effects on hormone
responsiveness and receptor signaling in human cancer cells. EGF, Epidermal growth factor. 18
I3C Targets Multiple Pathways
•

•

•

•

I3C and DIM have potent growth inhibitory and apoptosis inducing effects
on human and animal cancer cells by targeting multiple cellular signaling
pathways in vitro
Their inhibitory effects on cancer cell growth are through the modulation
of genes that are related to the control of cell proliferation, cell cycle,
apoptosis, signal transduction, oncogenesis, and transcription regulation
Their pleiotropic effects on cancer cells through targeting multiple cellular
signaling pathways including NF-κB, Akt, MAPK, Wnt, Notch, and
androgen receptor (AR)
Could be useful either alone or in combination with conventional
therapeutics for the prevention of tumor progression and/or treatment of
human malignancies
Sarkar & Li, Cancer Treat Rev. 2009 November ; 35(7): 597–607
Chinni SR et al., Oncogene 2001;20:2927–36
Li Y et al., J Nutr 2003;133:1011–9
Mukhopadhyay A et al., Oncogene 2001;20:7597–609.
Shao ZM et al., Int J Cancer 2002;98:234–40.

19
NF-κB, Akt, and Notch signaling pathways altered by isoflavone, I3C,
DIM, and curcumin
20
Targeting Multiple Signals
•

Inactivation of NF-κB is mechanistically linked with growth inhibitory and
apoptosis promoting activity
– Inhibition of NF-κB through modulation of IKK and IκB

•

Inhibition of Akt signaling (Akt responsible for cancer development and
progression)
– Decreased phosphorylated Akt protein at Ser473 and the Akt kinase activity

•

inhibition of Wnt signaling
– By up-regulating GSK-3β, enhanced GSK-3β binding to β-catenin, and
increased the phosphorylation of β-catenin

•

Also inhibitory effects on Notch signaling, resulting in the inhibition of
cancer cell growth
Sarkar & Li, Cancer Treat Rev. 2009 November ; 35(7): 597–607
Akiyama T et al., J Biol Chem 1987;262:5592–5
Li Y et al., J Biol Chem 2008;283:27707–16
Wang Z et al., Mol Cancer Ther 2006;5:483–93
Wnt and AR signaling pathways altered by natural products such as
isoflavone, I3C, DIM, etc.
22
Reported Phase I Study
•
•

Phase I trial of indole-3-carbinol (I3C) in 17 women (1 postmenopausal and 16
premenopausal) from a high-risk breast cancer cohort
After a 4-week placebo run-in period, subjects ingested 400 mg I3C daily for 4 weeks
followed by a 4-week period of 800 mg I3C daily
– these chronic doses were tolerated well by all subjects
– hormonal variables were measured near the end of the placebo and dosing periods,
including determination of the urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio
– serum estradiol, progesterone, luteinizing hormone, follicle-stimulating hormone, and sex
hormone binding globulin showed no significant changes in response to I3C
– comparing the results of placebo and the 800 mg daily dose period, CYP1A2 was elevated
by I3C in 94% of the subjects, NAT-2 activities decreased, Xanthine oxidase was not
affected. Lymphocyte glutathione S-transferase activity increased by 69% ; also inrease in
the urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio in response to I3C
– maximal increase was observed with the 400 mg daily dose of I3C, with no further increase
found at 800 mg daily
– with hydroxylated estrone metabolites is a biomarker for chemoprevention, 400 mg I3C
daily will elicit a maximal protective effect.

Reed GA at al., Cancer Epidemiol Biomarkers Prev. 2005 Aug;14,1953-60.

23
Example of Reported Phase II Studies
•

Therapeutic benefits of indole-3-carbinol (I3C) in the management of vulvar intraepithelial
neoplasia (VIN)
–
–
–
–
–

–
–
–
–

Women (n=12) with histologically confirmed high-grade VIN were randomized to receive 200 and
400 mg/day of I3C
Symptomatology by visual analog scale and vulvoscopic appearance were assessed at recruitment, 6
weeks, 3 months, and 6 months
Tissue biopsy to determine histologic response was obtained at completion of the study period
Urine samples were obtained at each visit to determine 2-hydroxyestrone to 16-alphahydroxyestrone ratios.
There was a significant improvement in symptomatology with the introduction of I3C (itch, P= 0.018;
pain, P= 0.028). Lesion size and severity were also significantly reduced (size, P= 0.005; appearance,
P= 0.046)
also a significant increase in 2-hydroxyestrone to 16-alpha-hydroxyestrone ratio following
commencement of I3C, P= 0.05
tissue biopsy from the worst-affected vulval areas revealed no improvement in grade of VIN during
the 6-month period, P= 0.317
no significant differences in results between those women taking 200 mg/day of I3C and those on
400 mg/day
study has shown significant clinical improvement in symptomatology and vulvoscopic appearance of
VIN with I3C therapy. Further clinical and scientific investigations are required to support these
preliminary findings.
Naik R et al.,Int J Gynecol Cancer, 2006 Mar-Apr;16(2):786-90

24
Example of Reported Phase II Studies..
•

Randomized, double-blind, placebo-controlled, parallel group study enrolled pre(n=47) and post-menopausal (n=49) women who were not on contraceptives or
hormone replacement therapy
– A supplement containing 200 mg of I3C & 10 mg of HMR lignan along with other minor
herbal constituents, was given to the treatment group
– placebo group received capsules containing microcrystalline cellulose
– at baseline and study end (day 28), blood samples were analyzed for serum
enterolactone concentrations, and morning urine samples were evaluated for estrogen
metabolites
– pre-menopausal women receiving the HMR lignan/I3C upplement had a significant
increase (p=0.003) in urinary 2-hydroxyestrone (2-OHE) concentrations and in 2:16 OHE
ratio (p=0.016)
– post-menopausal women receiving the supplement had a significant increase in urinary
2-OHE concentrations (p=0.035)
– pre- and post-menopausal groups combined, a significant increase in urinary 2-OHE
concentrations (p=0.001) and a trend (p=0.074) toward increased 2:16-OHE ratio were
observed
– authors concluded that HMR lignan/I3C supplementation significantly increased
estrogen C-2 hydroxylation, which may reduce the risk for breast and other estrogenrelated cancers.
Laidlaw M et al., Breast Cancer. 2010 Dec 16;4:85-95.

25
Indole-3-Carbinol in Treating Patients With PSA
Recurrence After Surgery for Prostate Cancer
•

•

•
•
•
•

•

OBJECTIVES: 1) Determine the feasibility of Brassica vegetable intake and indole-3-carbinol
supplement use in patients with prostate cancer with prostate-specific antigen (PSA)
recurrence after prostatectomy. 2) Identify adverse events in these patients. 3) Quantify the
effects of each intervention on PSA in these patients.
Patients (n not given) are stratified by pretreatment prostat-specific antigen (PSA) growth
rate (low [0.00-0.15] vs medium [0.16-0.30] vs high [> 0.30]). They are randomized to 1 of 3
treatment arms, and randomization status to arms II and III is double-blinded.
Arm I (Brassica vegetables): Patients consume Brassica vegetables at least 2 servings (½
cup/serving) daily for 6 months
Arm II (Placebo): Patients receive oral placebo once daily for 6 months.
Arm III (Indole-3-carbinol supplement): Patients receive oral indole-3-carbinol supplement
(capsules) once daily for 6 months.
Blood and urine samples (for urinary isothiocyanate levels) are collected at baseline and at 2,
4, and 6 months. Medical records are reviewed for prostate cancer-related information,
surgical dates, dose and type of radiation, and PSA history.
RESULTS NOT PUBLISHED YET
26
Peculiarities
• Protocol dependent effects
– I3C is a very powerful inhibitor of tumor formation in rats, mice, and
other species, including trout
– It has very interesting protocol-dependent effects
• e.g., if given to trout before and during exposure to aflatoxin (potent liver
carcinogen), it inhibits liver cancer
• if given the aflatoxin first, and then stop treatment and give indole-3-carbinol, the
indole-3-carbinol actually promotes liver cancer

• Low affinity for nuclear factors
– despite clear modulating effects on the trancrition factors
– dynamics among I3C/DIM & and promoter regions of ER, AhR and Sp1 may arise from
interactive regulation of transcription factors
– other potential sites where I3C/DIM may modulate the expression of a variety of cancerrelated genes?

27
Disease Targets
• Cancer
–
–
–
–

Prostate
Breast
Colon
HPV related
• Cervical Intraepithelial Neoplasia
• Vulvar Intraepithelial Neoplasia
• Recurrent Respiratory Papillomatosis

• Autoimmune and Inflammatory
–
–
–
–
–

Systemic lupus erythematosus (SLE)
Obesity
Rheumatoid & Osteo- Arthritis
IBS
Biochemical failure

28
ClinicalTrials.Gov

29
Non-clinical & Animal Studies Required
• For an IND (up to Phase I only)
• Demonstrate through screening tests
– Ames (mutagenicity) is negative
– Clastogenicity (chromosome damage) is negative
– hERG (cardiac safety) is negative

• Animal Studies
–
–
–
–
–
–
–

Pharmacology (efficacy; animal proof of principle) studies
A rodent general toxicology study of at least 14 days or more
A non-rodent general toxicology study of at least 14 days or more
Genotoxicity studies (GLP preferred)
Safety pharmacology studies
ADME
Analytical assays
30
Animal Studies contd..
• Dose levels
– Usually 3 dose groups and a control
• Want to see toxicity at highest dose
• Would like to see no toxicity at low does that are near the clinical dose
• Typical safety factor between a “clean” dose level (NOAEL = no observed
adverse effects level) and the clinical starting dose is 10X based on mg/m2

• Rat or Mouse? Dog or Monkey?
– Relevant species
• Metabolism similar to humans
• Pharmacology
– Species should have the pharmacological target
– Some species very sensitive to some drugs
» eg rats and NSAIDS, dogs and glucocorticoid steroids

• Required amount of drug should be available
31
Ideas on Preclinical Efficacy Studies
•
•

First, a comparative list of desirable anti-inflammatory and undesirable
pro-inflammatory properties be prepared
Cytokines to be measured
– anti-inflammatory: IL-2, IL-6 & IL-10
– pro-inflammatory: TNFα, IL-1, IFNγ

•

Undesirable properties of glucocorticoids
– weight gain, glucose tolerance, LFT elevation, decreased bone density,
decreased lymphocyte count, …

•
•
•

Study in rats – validated model
End-points: measurement of anti-inflammatory parameters for validation
of efficacy, body weight, Cytokines, LFT, and lymphocytes
Study duration: > 30 days

32
Thanks

33

Contenu connexe

Tendances

Tendances (20)

Inulin and its Extraction Methods
Inulin and its Extraction MethodsInulin and its Extraction Methods
Inulin and its Extraction Methods
 
Glycation
Glycation Glycation
Glycation
 
Lineweaver - Burk plot.pptx
Lineweaver - Burk plot.pptxLineweaver - Burk plot.pptx
Lineweaver - Burk plot.pptx
 
Age final
Age finalAge final
Age final
 
Allosteric enzymes
Allosteric enzymesAllosteric enzymes
Allosteric enzymes
 
Chymotrypsin
ChymotrypsinChymotrypsin
Chymotrypsin
 
Sphingolipids
SphingolipidsSphingolipids
Sphingolipids
 
Glycolipids
GlycolipidsGlycolipids
Glycolipids
 
Chymotrypsin Serine Protease Mechanism
Chymotrypsin Serine Protease MechanismChymotrypsin Serine Protease Mechanism
Chymotrypsin Serine Protease Mechanism
 
Protein purification techniques
Protein purification techniquesProtein purification techniques
Protein purification techniques
 
Cholesterol Biosynthesis
Cholesterol BiosynthesisCholesterol Biosynthesis
Cholesterol Biosynthesis
 
URONIC ACID PATHWAY
URONIC ACID PATHWAYURONIC ACID PATHWAY
URONIC ACID PATHWAY
 
Proteoglycans and glycoproteins
Proteoglycans and glycoproteinsProteoglycans and glycoproteins
Proteoglycans and glycoproteins
 
Ionophores
IonophoresIonophores
Ionophores
 
Eicosanoids
EicosanoidsEicosanoids
Eicosanoids
 
Eicosanoid synthesis
Eicosanoid synthesisEicosanoid synthesis
Eicosanoid synthesis
 
ATP- The universal energy currency of cell
ATP- The universal energy currency of cellATP- The universal energy currency of cell
ATP- The universal energy currency of cell
 
Suicide inhibitors
Suicide inhibitorsSuicide inhibitors
Suicide inhibitors
 
Advanced Glycation Endproducts and diabetes
Advanced Glycation Endproducts and diabetes Advanced Glycation Endproducts and diabetes
Advanced Glycation Endproducts and diabetes
 
Metabolism of mucopolysaccharides
Metabolism of mucopolysaccharidesMetabolism of mucopolysaccharides
Metabolism of mucopolysaccharides
 

Similaire à Indole 3-Carbinol

Broccolinate
BroccolinateBroccolinate
Broccolinate
Tim Pate
 
Seminar slides Final-2015
Seminar slides Final-2015Seminar slides Final-2015
Seminar slides Final-2015
Sushanta Sarkar
 
Mitochondrial dynamics and cancer (2)
Mitochondrial dynamics and cancer (2)Mitochondrial dynamics and cancer (2)
Mitochondrial dynamics and cancer (2)
soumik1997
 
2006-04-10 Thesis
2006-04-10 Thesis2006-04-10 Thesis
2006-04-10 Thesis
David Chiu
 
Pectin Cancer Suppression
Pectin Cancer SuppressionPectin Cancer Suppression
Pectin Cancer Suppression
Keerthana Rajan
 
sakshi yadav major project ppt.pptx
sakshi yadav major project ppt.pptxsakshi yadav major project ppt.pptx
sakshi yadav major project ppt.pptx
JMuthukumaran
 

Similaire à Indole 3-Carbinol (20)

Cancer Cells and anticancer effect of some plants and materials
Cancer Cells and anticancer effect of some plants and materialsCancer Cells and anticancer effect of some plants and materials
Cancer Cells and anticancer effect of some plants and materials
 
The PTEN and PI3-Kinase Pathway in Cancer ppt
The PTEN and PI3-Kinase Pathway in Cancer pptThe PTEN and PI3-Kinase Pathway in Cancer ppt
The PTEN and PI3-Kinase Pathway in Cancer ppt
 
Immunomodulatory Potential of Probiotic Lactobacillus casei
Immunomodulatory Potential of Probiotic Lactobacillus caseiImmunomodulatory Potential of Probiotic Lactobacillus casei
Immunomodulatory Potential of Probiotic Lactobacillus casei
 
Broccolinate
BroccolinateBroccolinate
Broccolinate
 
UCSF Hyperpolarized MR #8-1: Cancer (2019)
UCSF Hyperpolarized MR #8-1: Cancer (2019)UCSF Hyperpolarized MR #8-1: Cancer (2019)
UCSF Hyperpolarized MR #8-1: Cancer (2019)
 
The expression of ITPK in normal colon and colorectal cancer cells - Paper
The expression of ITPK in normal colon and colorectal cancer cells - PaperThe expression of ITPK in normal colon and colorectal cancer cells - Paper
The expression of ITPK in normal colon and colorectal cancer cells - Paper
 
Seminar slides Final-2015
Seminar slides Final-2015Seminar slides Final-2015
Seminar slides Final-2015
 
Food as Medicine:Turkey Tail Mushroom, Trametes versicolor
Food as Medicine:Turkey Tail Mushroom, Trametes versicolorFood as Medicine:Turkey Tail Mushroom, Trametes versicolor
Food as Medicine:Turkey Tail Mushroom, Trametes versicolor
 
Wp seidman 12
Wp seidman 12Wp seidman 12
Wp seidman 12
 
Mitochondrial dynamics and cancer (2)
Mitochondrial dynamics and cancer (2)Mitochondrial dynamics and cancer (2)
Mitochondrial dynamics and cancer (2)
 
Cd117 Dako Research Paper
Cd117 Dako Research PaperCd117 Dako Research Paper
Cd117 Dako Research Paper
 
Molecular biology seminar.pptx
Molecular biology seminar.pptxMolecular biology seminar.pptx
Molecular biology seminar.pptx
 
Molecular biology seminar.pptx
Molecular biology seminar.pptxMolecular biology seminar.pptx
Molecular biology seminar.pptx
 
Seminario biologia molecular
Seminario biologia molecular Seminario biologia molecular
Seminario biologia molecular
 
pone.0143384
pone.0143384pone.0143384
pone.0143384
 
Genetic Variations in Drug Transporters
Genetic Variations in Drug TransportersGenetic Variations in Drug Transporters
Genetic Variations in Drug Transporters
 
2006-04-10 Thesis
2006-04-10 Thesis2006-04-10 Thesis
2006-04-10 Thesis
 
Proteasome inhibitors in treatment of multiple myeloma
Proteasome inhibitors in treatment of multiple myelomaProteasome inhibitors in treatment of multiple myeloma
Proteasome inhibitors in treatment of multiple myeloma
 
Pectin Cancer Suppression
Pectin Cancer SuppressionPectin Cancer Suppression
Pectin Cancer Suppression
 
sakshi yadav major project ppt.pptx
sakshi yadav major project ppt.pptxsakshi yadav major project ppt.pptx
sakshi yadav major project ppt.pptx
 

Plus de Bhaswat Chakraborty

Plus de Bhaswat Chakraborty (20)

Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
 
Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019
 
Respiratory studies right approach in designs dia 11 april 2019 r
Respiratory studies right approach  in designs dia 11 april 2019 rRespiratory studies right approach  in designs dia 11 april 2019 r
Respiratory studies right approach in designs dia 11 april 2019 r
 
Simplifying study designs and statistical models for new dose & dosage forms ...
Simplifying study designs and statistical models for new dose & dosage forms ...Simplifying study designs and statistical models for new dose & dosage forms ...
Simplifying study designs and statistical models for new dose & dosage forms ...
 
Equivalence approches for complex generics DIA 11 april 2019
Equivalence approches for complex generics DIA 11 april 2019 Equivalence approches for complex generics DIA 11 april 2019
Equivalence approches for complex generics DIA 11 april 2019
 
Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018
 
Writing scientific papers FINALDec 2018
Writing scientific papers FINALDec 2018Writing scientific papers FINALDec 2018
Writing scientific papers FINALDec 2018
 
Multidisc review of NDAs and BLAs nipicon 2018 Dr. Chakraborty
Multidisc review of NDAs and BLAs nipicon 2018 Dr. ChakrabortyMultidisc review of NDAs and BLAs nipicon 2018 Dr. Chakraborty
Multidisc review of NDAs and BLAs nipicon 2018 Dr. Chakraborty
 
Teaching by stories, anecdotes and historical facts sept 25 2018
Teaching by stories, anecdotes and historical facts sept 25 2018Teaching by stories, anecdotes and historical facts sept 25 2018
Teaching by stories, anecdotes and historical facts sept 25 2018
 
Orientation and Adaptation for Post-Graduate Pharmacy Programs
Orientation and Adaptation for Post-Graduate Pharmacy ProgramsOrientation and Adaptation for Post-Graduate Pharmacy Programs
Orientation and Adaptation for Post-Graduate Pharmacy Programs
 
Plagiarism and Techniques to Avoid Plagiarism
Plagiarism and Techniques to Avoid PlagiarismPlagiarism and Techniques to Avoid Plagiarism
Plagiarism and Techniques to Avoid Plagiarism
 
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
 
Ethics in Pharmacy
Ethics in Pharmacy Ethics in Pharmacy
Ethics in Pharmacy
 
Pharmacists in Drug Discovery & Development
Pharmacists in Drug Discovery & Development Pharmacists in Drug Discovery & Development
Pharmacists in Drug Discovery & Development
 
Clinical Development of Biosimilars
Clinical Development of Biosimilars Clinical Development of Biosimilars
Clinical Development of Biosimilars
 
Challenges in Phase III Cancer Clinical Trials
Challenges in Phase III Cancer Clinical Trials Challenges in Phase III Cancer Clinical Trials
Challenges in Phase III Cancer Clinical Trials
 
Bioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug ProductsBioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug Products
 
Bioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug ProductsBioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug Products
 
Protein binding of drugs and screening of drugs by physicochemical properties
Protein binding of drugs  and screening of drugs by physicochemical propertiesProtein binding of drugs  and screening of drugs by physicochemical properties
Protein binding of drugs and screening of drugs by physicochemical properties
 
Developing Protocols & Procedures for CT Data Integrity
Developing Protocols & Procedures for CT Data Integrity Developing Protocols & Procedures for CT Data Integrity
Developing Protocols & Procedures for CT Data Integrity
 

Dernier

Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
9953056974 Low Rate Call Girls In Saket, Delhi NCR
 

Dernier (20)

Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
 
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
 
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
 
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated  Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...Top Rated  Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
 
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
 
Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...
Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...
Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
 
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
 
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
 
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service AvailableCall Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
 
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
 
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
 
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
 
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeTop Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
 
9630942363 Genuine Call Girls In Ahmedabad Gujarat Call Girls Service
9630942363 Genuine Call Girls In Ahmedabad Gujarat Call Girls Service9630942363 Genuine Call Girls In Ahmedabad Gujarat Call Girls Service
9630942363 Genuine Call Girls In Ahmedabad Gujarat Call Girls Service
 
Coimbatore Call Girls in Thudiyalur : 7427069034 High Profile Model Escorts |...
Coimbatore Call Girls in Thudiyalur : 7427069034 High Profile Model Escorts |...Coimbatore Call Girls in Thudiyalur : 7427069034 High Profile Model Escorts |...
Coimbatore Call Girls in Thudiyalur : 7427069034 High Profile Model Escorts |...
 
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
 
Call Girls Madurai Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Madurai Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Madurai Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Madurai Just Call 9630942363 Top Class Call Girl Service Available
 
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
 
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
 

Indole 3-Carbinol

  • 1. Indole-3-Carbinol Properties, Targets, Required Animal Data Dr. Bhaswat S. Chakraborty 1
  • 2. • • Indole-3-carbinol (I3C) belongs to dietary polyphenols which include flavonoids, stillbenes, lignas, and phenolic acids I3C is produced by the breakdown of the glucosinolate viz. glucobrassicin – found at relatively high levels in cruciferous vegetables, e.g., broccoli, cabbage, cauliflower, brussels sprouts, collard greens and kale – cruciferous vegetables differ from other classes of vegetables in that they are rich sources of sulfur-containing compounds (glucosinolates) – cruciferous vegetables are associated with lower risk of several types of cancer (epidemiologic evidence) 2
  • 3. • I3C: – – – – – – – – Off-white powder; mixes with water Average Molecular Weight 147.1739 Melting Point 90 °C Water Solubility 3.75 g/L pKa ? (can act as both an electron donor & acceptor) pH (1% solution) ? storage temp. 2-8°C Oral formulations can be made 3
  • 4. • • • Hydrolysis of glucobrassicin by myrosinase at neutral pH results in an unstable indole isothiocyanate that degrades to form I3C and a thiocyanate ion At acidic pH (stomach), I3C condenses to dimers (3,3'-diindolylmethane, DIM) & trimers (Cyclononal tri-indole, CT) When cruciferous vegetables are cooked (inactivating myrosinase), glucobrassicin hydrolysis by intestinal bacteria still results in some I3C formation, whereas DIM & CT do not form in alkaline pH of intestine 4
  • 5. QSAR & CoMFA • • • • • At least one 3D-QSAR Comparative Molecular Field Analysis (CoMFA) study of 14 DIM derivatives is reported The CoMFA model derived from DIM analogues proved a good predictive ability Some newly designed compounds exhibited 3-fold more potent radical scavenging activity than reference substance Vitamin E in DPPH model expressed by IC50 values The primary antitumor screening essay showed that some DIM derivatives designed exhibited the inhibitory activities to some tumor cell growth at relatively high concentration, and DIM was the most effective among them Relaiable 3D-QSAR model can be developed for radical scavenging activities and anticancer assays in vitro. Benabadji SH et al., Acta Pharmacol Sin 2004; 25: 666-671 5
  • 6. PK of I3C • • Very little data Gastric acid converts I3C to active metabolites DIM and indolylcarbazole, which are further metabolized in the liver – most metabolites are excreted through the feces – Conversion from I3C into DIM not only requires a precise acidity, it requires time. This conversion may proceed slowly, requiring more time than most foods typically spend in the intestinal tract • • • Following an oral dose of I3C in humans, only DIM and no I3C was found circulating in the bloodstream of human subjects Over 90% of an oral dose of I3C is converted into non-DIM condensation products of uncertain structure, uptake and activity I3C induces CYP 1A2 and can reduce serum concentration of drugs metabolized by this enzyme Arneson, DW et al., Proceedings of the American Association for Cancer Research, 1999 Mar; (40): #2833 Cover CM, et al. Cancer Res 1999; 59:1244-51 Yoshida M et al., Carcinogenesis. 2004 Nov;25(11):2257-64 6
  • 8. • Several dietary polyphenol compounds (e.g. resveratrol, genistein, catechin, and indole-3-carbinol) have been studied for inflammation and cancer. • The potential molecular mechanisms of their antiinflammatory activities have also been suggested to include inhibition of enzymes related to inflammation: – – – – – cyclooxygenase and lipoxygenase PPAR NOS NF-κB NAG-1 • Mainly – AA-Dependent pathway – AA-Independent pathway Baek SJ et al. Carcinogenesis, 2004;25:2425-32. Baek SJ et al. Carcinogenesis, 2002;23:425-34. Lee SH, et al. Biochem Biophys Res Commun, 2005;328:63-9. Wilson LC et al. Int J Cancer 2003;105:747-53. 8
  • 9. AA- Dependent Mechanisms • • Aspirin and other NSAIDs block COX-1 and COX-2 The role of COX inhibition by I3C is not very clear but all NF-κB-regulated gene products including COX-2 are down-regulated by I3C – however, some dietary polyphenols, such as galangin and luteolin, and curcumin inhibit AA peroxidation • • • • • Flavonols, including kaempferol, quercetin, morin and myricetin, were found to be 5LOX inhibitors. Hamamelitannin and the galloylated proanthocyanidins were found to be the most potent inhibitors of 5-LOX. In contrast, there are few reports regarding 12-LOX inhibition. Using bovine PMNs and 12-LOX from bovine platelets, kuwanson C and quercetin potently inhibit 12-LOX activity Again, LOX inhibition by I3C is not very clear but all NF-κB-regulated gene products including LOX are down-regulated by I3C and DIM Both COX and LOX are blocked by curcumin Quercetin was found to be an effective inhibitor of PLA2 in human38 and rabbit39 leukocytes. Quercetagetin, kaempferol-3-O-galactoside, and scutellarein inhibited human recombinant synovial PLA2. Yoon J-H & Baek SJ, Yonsei Medical Journal 2005, 46, 585 - 596 9
  • 10. 10
  • 11. AA- Independent Mechanisms • • • • • • • • PPARs (nuclear hormone receptors) regulate many inflammatory cytokines at the transcriptional level, either enhancing or inhibiting inflammation process Genistein increased the expression of lipid catabolism genes (this effect is not estrogen receptordependent, but PPARα-dependent). EGCG also binds to PPARα. Amentoflavone up-regulates PPARγ expression in A549 human lung epithelial cells. Few studies regarded polyphenols as PPAR ligands, but it is probable that polyphenols may also affect PPAR protein expression, which results in the activation of the PPAR pathway Effect of I3C on PPARs not reported Nitric oxide synthase (NOS) endothelial NOS (eNOS), neuronal NOS (nNOS) and inducible NOS (iNOS): many polyphenols, including 6-gingerol,64 EGCG,65 resveratrol, indole-3-carbinol, and oroxylin A, inhibit NOS expression in LPS-induced RAW264.7 cells (these effects are probably mediated by NF-κB) Nuclear transcription factor κB (NF-κB): Quercetin was reported to suppress TNF-α induced expression of IL-8 and monocyte chemoattractant protein (MCP-1) due to its ability to inhibit the activation of NF-κB. Quercetin also inhibited the NF-κB pathway without any modification of c-Jun N- terminal kinase activity both in vivo & in vitro Recently, it has been reported that I3C inhibits NF-κB and NF-κB-regulated gene expression. NAG-1 (NSAID activated gene-1): I3C and other polyphenols induce NAG-1 expression, except (-) -epicatechin (EC) and (-)-epigallocatechin (EGC), indicating the structure-specific expression of NAG-1 induction Yoon J-H & Baek SJ, Yonsei Medical Journal 2005, 46, 585 - 596 11
  • 13. Anticancer Properties • I3C & DIM are good candidates for cancer prevention. Several studies demonstrate that they – – – – • can cause cell cycle arrest and apoptosis in cancer cell lines have antiangiogenic activity inhibit tobacco smoke-induced lung adenocarcinoma in mice I3C enhances efficacy of gemcitabine and acts synergistically with bortezomib in vitro. Clinical trial data show that I3C is effective in treatment of precancerous cervical dysplasia and vulvar intraepithelial neoplasia – In premenopausal women, a supplement containing I3C and 7-hydroxymatairesinol significantly increased the urinary 2:16-hydroxyestrone ratio, a known biomarker for the reduction of breast cancer risk • • I3C also stimulates detoxification enzymes in the gut and liver I3C is generally well tolerated when taken orally – it may, however, promote tumor growth in animals that have been exposed to carcinogens – because it induces cytochrome P450 enzymes, I3C may interact with several medications 13
  • 14. Nuclear factors modulated by I3C • Four nuclear transcription factors interact with I3C and DIM – – – – • estrogen receptor (ER) Sp1 nuclear factor кB (NFкB) aryl hydrocarbonreceptor (AhR) These may account for changes in downstream events in normal and neoplastic cells. Y.S. Kim, J.A. Milner. J Nutri Biochem 16 (2005) 65–73 14
  • 15. DIM Resource Centre, University of California at Berkeley 15
  • 16. DIM Resource Centre, University of California at Berkeley 16
  • 17. 17 DIM Resource Centre, University of California at Berkeley
  • 18. Chemical structures of I3C and DIM and summary of their key modulatory effects on hormone responsiveness and receptor signaling in human cancer cells. EGF, Epidermal growth factor. 18
  • 19. I3C Targets Multiple Pathways • • • • I3C and DIM have potent growth inhibitory and apoptosis inducing effects on human and animal cancer cells by targeting multiple cellular signaling pathways in vitro Their inhibitory effects on cancer cell growth are through the modulation of genes that are related to the control of cell proliferation, cell cycle, apoptosis, signal transduction, oncogenesis, and transcription regulation Their pleiotropic effects on cancer cells through targeting multiple cellular signaling pathways including NF-κB, Akt, MAPK, Wnt, Notch, and androgen receptor (AR) Could be useful either alone or in combination with conventional therapeutics for the prevention of tumor progression and/or treatment of human malignancies Sarkar & Li, Cancer Treat Rev. 2009 November ; 35(7): 597–607 Chinni SR et al., Oncogene 2001;20:2927–36 Li Y et al., J Nutr 2003;133:1011–9 Mukhopadhyay A et al., Oncogene 2001;20:7597–609. Shao ZM et al., Int J Cancer 2002;98:234–40. 19
  • 20. NF-κB, Akt, and Notch signaling pathways altered by isoflavone, I3C, DIM, and curcumin 20
  • 21. Targeting Multiple Signals • Inactivation of NF-κB is mechanistically linked with growth inhibitory and apoptosis promoting activity – Inhibition of NF-κB through modulation of IKK and IκB • Inhibition of Akt signaling (Akt responsible for cancer development and progression) – Decreased phosphorylated Akt protein at Ser473 and the Akt kinase activity • inhibition of Wnt signaling – By up-regulating GSK-3β, enhanced GSK-3β binding to β-catenin, and increased the phosphorylation of β-catenin • Also inhibitory effects on Notch signaling, resulting in the inhibition of cancer cell growth Sarkar & Li, Cancer Treat Rev. 2009 November ; 35(7): 597–607 Akiyama T et al., J Biol Chem 1987;262:5592–5 Li Y et al., J Biol Chem 2008;283:27707–16 Wang Z et al., Mol Cancer Ther 2006;5:483–93
  • 22. Wnt and AR signaling pathways altered by natural products such as isoflavone, I3C, DIM, etc. 22
  • 23. Reported Phase I Study • • Phase I trial of indole-3-carbinol (I3C) in 17 women (1 postmenopausal and 16 premenopausal) from a high-risk breast cancer cohort After a 4-week placebo run-in period, subjects ingested 400 mg I3C daily for 4 weeks followed by a 4-week period of 800 mg I3C daily – these chronic doses were tolerated well by all subjects – hormonal variables were measured near the end of the placebo and dosing periods, including determination of the urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio – serum estradiol, progesterone, luteinizing hormone, follicle-stimulating hormone, and sex hormone binding globulin showed no significant changes in response to I3C – comparing the results of placebo and the 800 mg daily dose period, CYP1A2 was elevated by I3C in 94% of the subjects, NAT-2 activities decreased, Xanthine oxidase was not affected. Lymphocyte glutathione S-transferase activity increased by 69% ; also inrease in the urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio in response to I3C – maximal increase was observed with the 400 mg daily dose of I3C, with no further increase found at 800 mg daily – with hydroxylated estrone metabolites is a biomarker for chemoprevention, 400 mg I3C daily will elicit a maximal protective effect. Reed GA at al., Cancer Epidemiol Biomarkers Prev. 2005 Aug;14,1953-60. 23
  • 24. Example of Reported Phase II Studies • Therapeutic benefits of indole-3-carbinol (I3C) in the management of vulvar intraepithelial neoplasia (VIN) – – – – – – – – – Women (n=12) with histologically confirmed high-grade VIN were randomized to receive 200 and 400 mg/day of I3C Symptomatology by visual analog scale and vulvoscopic appearance were assessed at recruitment, 6 weeks, 3 months, and 6 months Tissue biopsy to determine histologic response was obtained at completion of the study period Urine samples were obtained at each visit to determine 2-hydroxyestrone to 16-alphahydroxyestrone ratios. There was a significant improvement in symptomatology with the introduction of I3C (itch, P= 0.018; pain, P= 0.028). Lesion size and severity were also significantly reduced (size, P= 0.005; appearance, P= 0.046) also a significant increase in 2-hydroxyestrone to 16-alpha-hydroxyestrone ratio following commencement of I3C, P= 0.05 tissue biopsy from the worst-affected vulval areas revealed no improvement in grade of VIN during the 6-month period, P= 0.317 no significant differences in results between those women taking 200 mg/day of I3C and those on 400 mg/day study has shown significant clinical improvement in symptomatology and vulvoscopic appearance of VIN with I3C therapy. Further clinical and scientific investigations are required to support these preliminary findings. Naik R et al.,Int J Gynecol Cancer, 2006 Mar-Apr;16(2):786-90 24
  • 25. Example of Reported Phase II Studies.. • Randomized, double-blind, placebo-controlled, parallel group study enrolled pre(n=47) and post-menopausal (n=49) women who were not on contraceptives or hormone replacement therapy – A supplement containing 200 mg of I3C & 10 mg of HMR lignan along with other minor herbal constituents, was given to the treatment group – placebo group received capsules containing microcrystalline cellulose – at baseline and study end (day 28), blood samples were analyzed for serum enterolactone concentrations, and morning urine samples were evaluated for estrogen metabolites – pre-menopausal women receiving the HMR lignan/I3C upplement had a significant increase (p=0.003) in urinary 2-hydroxyestrone (2-OHE) concentrations and in 2:16 OHE ratio (p=0.016) – post-menopausal women receiving the supplement had a significant increase in urinary 2-OHE concentrations (p=0.035) – pre- and post-menopausal groups combined, a significant increase in urinary 2-OHE concentrations (p=0.001) and a trend (p=0.074) toward increased 2:16-OHE ratio were observed – authors concluded that HMR lignan/I3C supplementation significantly increased estrogen C-2 hydroxylation, which may reduce the risk for breast and other estrogenrelated cancers. Laidlaw M et al., Breast Cancer. 2010 Dec 16;4:85-95. 25
  • 26. Indole-3-Carbinol in Treating Patients With PSA Recurrence After Surgery for Prostate Cancer • • • • • • • OBJECTIVES: 1) Determine the feasibility of Brassica vegetable intake and indole-3-carbinol supplement use in patients with prostate cancer with prostate-specific antigen (PSA) recurrence after prostatectomy. 2) Identify adverse events in these patients. 3) Quantify the effects of each intervention on PSA in these patients. Patients (n not given) are stratified by pretreatment prostat-specific antigen (PSA) growth rate (low [0.00-0.15] vs medium [0.16-0.30] vs high [> 0.30]). They are randomized to 1 of 3 treatment arms, and randomization status to arms II and III is double-blinded. Arm I (Brassica vegetables): Patients consume Brassica vegetables at least 2 servings (½ cup/serving) daily for 6 months Arm II (Placebo): Patients receive oral placebo once daily for 6 months. Arm III (Indole-3-carbinol supplement): Patients receive oral indole-3-carbinol supplement (capsules) once daily for 6 months. Blood and urine samples (for urinary isothiocyanate levels) are collected at baseline and at 2, 4, and 6 months. Medical records are reviewed for prostate cancer-related information, surgical dates, dose and type of radiation, and PSA history. RESULTS NOT PUBLISHED YET 26
  • 27. Peculiarities • Protocol dependent effects – I3C is a very powerful inhibitor of tumor formation in rats, mice, and other species, including trout – It has very interesting protocol-dependent effects • e.g., if given to trout before and during exposure to aflatoxin (potent liver carcinogen), it inhibits liver cancer • if given the aflatoxin first, and then stop treatment and give indole-3-carbinol, the indole-3-carbinol actually promotes liver cancer • Low affinity for nuclear factors – despite clear modulating effects on the trancrition factors – dynamics among I3C/DIM & and promoter regions of ER, AhR and Sp1 may arise from interactive regulation of transcription factors – other potential sites where I3C/DIM may modulate the expression of a variety of cancerrelated genes? 27
  • 28. Disease Targets • Cancer – – – – Prostate Breast Colon HPV related • Cervical Intraepithelial Neoplasia • Vulvar Intraepithelial Neoplasia • Recurrent Respiratory Papillomatosis • Autoimmune and Inflammatory – – – – – Systemic lupus erythematosus (SLE) Obesity Rheumatoid & Osteo- Arthritis IBS Biochemical failure 28
  • 30. Non-clinical & Animal Studies Required • For an IND (up to Phase I only) • Demonstrate through screening tests – Ames (mutagenicity) is negative – Clastogenicity (chromosome damage) is negative – hERG (cardiac safety) is negative • Animal Studies – – – – – – – Pharmacology (efficacy; animal proof of principle) studies A rodent general toxicology study of at least 14 days or more A non-rodent general toxicology study of at least 14 days or more Genotoxicity studies (GLP preferred) Safety pharmacology studies ADME Analytical assays 30
  • 31. Animal Studies contd.. • Dose levels – Usually 3 dose groups and a control • Want to see toxicity at highest dose • Would like to see no toxicity at low does that are near the clinical dose • Typical safety factor between a “clean” dose level (NOAEL = no observed adverse effects level) and the clinical starting dose is 10X based on mg/m2 • Rat or Mouse? Dog or Monkey? – Relevant species • Metabolism similar to humans • Pharmacology – Species should have the pharmacological target – Some species very sensitive to some drugs » eg rats and NSAIDS, dogs and glucocorticoid steroids • Required amount of drug should be available 31
  • 32. Ideas on Preclinical Efficacy Studies • • First, a comparative list of desirable anti-inflammatory and undesirable pro-inflammatory properties be prepared Cytokines to be measured – anti-inflammatory: IL-2, IL-6 & IL-10 – pro-inflammatory: TNFα, IL-1, IFNγ • Undesirable properties of glucocorticoids – weight gain, glucose tolerance, LFT elevation, decreased bone density, decreased lymphocyte count, … • • • Study in rats – validated model End-points: measurement of anti-inflammatory parameters for validation of efficacy, body weight, Cytokines, LFT, and lymphocytes Study duration: > 30 days 32

Notes de l'éditeur

  1. Peroxisomes (also called microbodies) are organelles found in virtually all eukaryotic cells.They are involved in the catabolism of very long chain fatty acids, branched chain fatty acids, D-amino acids, polyamines, and biosynthesis of plasmalogens, i.e. ether phospholipids critical for the normal function of mammalian brains and lungs.They also contain approximately 10% of the total activity of two enzymes in the pentose phosphate pathway, which is important for energy metabolism.